- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06883786
Effects of Virtual Reality Hypnosis on Anxiety, Pain and Comfort in Oncology Patients During a Port-catheter Placement Procedure (VRH-PAC)
March 12, 2025 updated by: Audrey Vanhaudenhuyse, University of Liege
Interest of Virtual Reality Hypnosis to Decrease Anxiety, Pain, and Discomfort of Patients with Cancer Having to Undergo an Invasive Intervention
The port-catheter (PAC) is a longterm venous access device, frequently used in oncology patients.
The PAC is an invasive technique, consisting of a reservoir surgically implanted in the chest wall or upper arm, and arm and a catheter.
Patients can experience pain in the incision area after implantation, as well as anxiety before, during and after implantation.
Virtual reality hypnosis (VRH) is an innovative technique delivering clinical hypnosis to patients through virtual reality (VR).
The clinical applications of VRH are still little known.
We will assess the anxiety, comofrt, pain perception and pain unpleasantness of 102 cancer patients scheduled to receive a PAC.
The patients will be randomly divided into two groups.
Thefirst group will benefit from the usual care for the placement of the PAC (i.e., local anaesthesia), while the second will benefit from the VRH in addition to the usual care.
Pain perception, pain unpleasantness, anxiety, satisfaction, absorption, dissociation will be evaluated before and after the intervention.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Audrey Vanhaudenhuyse, PhD
- Phone Number: + 32 43 23 80 33
- Email: avanhaudenhuyse@chuliege.be
Study Contact Backup
- Name: Aminata Bicego, PhD
- Phone Number: +32 43 66 34 99
- Email: abicego@uliege.be
Study Locations
-
-
-
Liège, Belgium, 4000
- Chu of Liège
-
Contact:
- Aminata Bicego, PhD
- Phone Number: 003243663499
- Email: abicego@uliege.be
-
Contact:
- Audrey Vanhaudenhuyse, PI
- Phone Number: 003243668033
- Email: avanhaudenhuyse@chuliege.be
-
Contact:
- Yanis Mouheb, M.Sc.
-
-
Liège
-
Huy, Liège, Belgium, 4500
- CHR de Huy
-
Contact:
- Jean-François Dr. Maillart, M.D.
- Phone Number: +3285277154
- Email: jf.maillart@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Low auditory and/or visual acuity precludes the use of the device.
- Head or face wounds precluding the use of the device.
- Schizophrenia, dissociative disorder or any other psychiatric disorder.
- Non-proficiency in French (Research language).
- Patient under 18 years old.
- Phobia of deep water.
- Dizziness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual reality hypnosis
The VRH session, called Aqua+© (120 Version 1.1, HypnoVR SAS, Strasbourg, France) It is an immersive and contemplative virtual experience combining music, sounds, and/or a vocal audio recording relating a hypnotic scenario and a 3D virtual video.
The Aqua© VRH session follows the standard phases of hypnosis, beginning with induction, followed by suggestions, and ending with the exit of hypnosis.
|
Virtual reality hypnosis
|
|
No Intervention: Control
Usual care.
Local anesthesia only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety state
Time Frame: Before PAC intervention, immediately after PAC intervention
|
Anxiety state will be assessed using a numerical rating scale (NRS) ranging from 0 (no anxiety) to 10 (worst anxiety ever).
|
Before PAC intervention, immediately after PAC intervention
|
|
Pain intensity
Time Frame: Before PAC intervention, immediately after PAC intervention
|
Pain intensity will be assessed using a numerical rating scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable).
|
Before PAC intervention, immediately after PAC intervention
|
|
Pain unpleasantness
Time Frame: Before PAC intervention, immediately after PAC intervention
|
Pain unpleasantness will be assessed using a numerical rating scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable).
|
Before PAC intervention, immediately after PAC intervention
|
|
Comfort
Time Frame: Before PAC intervention, immediately after PAC intervention
|
Comfort will be assessed using a numerical rating scale (NRS) ranging from 0 (no comfort) to 10 (maximum comfort).
|
Before PAC intervention, immediately after PAC intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety trait
Time Frame: From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
The State-Trait Anxiety Inventory (STAI - Y) will be used to assess trait anxiety only.
Originally this questionnaire has two parts one dedicated to assess state anxiety and another to assess the trait anxiety.
Only the latter was used in this study.
STAI - Y Trait contains 20 items with 4 response options (1 = almost never, 2 = sometimes, 3 = often, 4 = almost always).
Total scores can range from 20 to 80, with higher scores indicating a higher level of anxiety.
|
From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
|
Dissociation trait
Time Frame: From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
The Dissociative Experience Scale is a self-reported questionnaire used to evaluate the presence, quantity, and type of dissociative experiences one might live in daily life.
It consists of 28 items arranged on an analog scale (from 0 to 100% measuring the frequency of dissociative experiences), and the total score ranges from 0 to 100.
There is a cutoff of 45 as a mean score to suggest a dissociative disorder.
This questionnaire is not a diagnostic instrument; it is designed only for screening, but it can suggest that a specific clinical assessment is needed.
|
From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
|
Dissociation state
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
Dissociation will be assessed using a numerical rating scale (NRS) ranging from 0 (no dissociation) to 10 (maximum dissociation).
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Absorption trait
Time Frame: From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
The Tellegen Absorption Scale consists of 34 true/false items , aiming to measure the absorption of a person, meaning the disposition for having episodes of a deep involvement that engage all the subject's resources (perceptual, imaginative, and cognitive).
The total score range is from 0 to 34.
The higher the score, the more one has a high propensity for absorption.
|
From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
|
Absorption state
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
Absorption will be assessed using a numerical rating scale (NRS) ranging from 0 (no Absorption) to 10 (maximum Absorption).
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Time perception
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
Time perception will be assessed with an open-ended question.
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Immersion tendencies
Time Frame: From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
Immersion propensity is the amount of sensory input the virtual reality system creates.
Will be assessed with the Immersion Propensity questionnaire.
The higher the score, the more one is immersed in the virtual environments.
|
From the day of the group assignment until beginning the PAC intervention, assessed up to two weeks
|
|
Satisfaction of the participant
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
Satisfaction will be assessed using a numerical rating scale (NRS) ranging from 0 (dissatisfied) to 10 (best satisfaction ever).
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Satisfaction of the surgeon
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
Satisfaction will be assessed using a numerical rating scale (NRS) ranging from 0 (dissatisfied) to 10 (best satisfaction ever).
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Medication
Time Frame: During PAC intervention, 24 hours after PAC intervention, 48 hours after PAC, 7 days after PAC
|
The medication will be collected in the medical record of the surgery.
|
During PAC intervention, 24 hours after PAC intervention, 48 hours after PAC, 7 days after PAC
|
|
Surgery duration
Time Frame: From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
The duration of the surgery will be collected in the medical record of the surgery.
|
From the day of the group assignment until completion of the PAC intervention, assessed up to two weeks
|
|
Fatigue
Time Frame: 24 hours after PAC intervention, 48 hours after PAC, 7 days after PAC
|
Fatigue will be assessed using a numerical rating scale (NRS) ranging from 0 (no fatigue) to 10 (worst fatigue ever).
|
24 hours after PAC intervention, 48 hours after PAC, 7 days after PAC
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
February 15, 2024
First Submitted That Met QC Criteria
March 12, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 12, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- VRH-PAC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.